Your browser doesn't support javascript.
loading
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
Lancet ; 362(9387): 859-68, 2003 Sep 13.
Article in En | MEDLINE | ID: mdl-13678973
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications, Infectious / Zidovudine / HIV Infections / HIV-1 / Infectious Disease Transmission, Vertical / Disease Transmission, Infectious / Anti-HIV Agents / Nevirapine Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Infant / Newborn / Pregnancy Country/Region as subject: Africa Language: En Journal: Lancet Year: 2003 Document type: Article Affiliation country: United States Country of publication: United kingdom
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications, Infectious / Zidovudine / HIV Infections / HIV-1 / Infectious Disease Transmission, Vertical / Disease Transmission, Infectious / Anti-HIV Agents / Nevirapine Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Infant / Newborn / Pregnancy Country/Region as subject: Africa Language: En Journal: Lancet Year: 2003 Document type: Article Affiliation country: United States Country of publication: United kingdom